Matthias Gotte, Department of Medical Microbiology and Immunology, University of Alberta, CanadaAlbert M. Berguis, Department of Biochemistry, McGill University, CanadaGreg Matlashewski, Department of Microbiology and Immunology, McGill University, CanadaDonald Sheppard, Department of Microbiology and Immunology, McGill University, CanadaMark A. Wainberg, Department of Microbiology and Immunology, McGill University, Canada

• Bacteria.- Origins of antibiotic resistance (Resistome).- Dissemination of antibiotic resistance.- Mechanisms of antibiotic resistance.-Strategies for combating antibiotic resistance.- Multiple-drug-resistant bacteria.- Resistant Tuberculosis.- MRSA.- Fungi.- Microevolution of drug resistance.- Environmental induction of azole resistance in medical molds.- Echinocandin resistance in medically relevant fungi.- Role of drug efflux in azole resistance.- Parasites.- Drug-resistant Leishmania.- Drug resistance in Helminth infections.- Drug resistance in Malaria.- Drug resistance in schistosome infections.- Drug resistance in trypanosome infections.- HIV.- Resistance to RT inhibitors.- Resistance to Integrase Inhibitors.- Resistance to Entry inhibitors.- Resistance Testing.- Virology.- Resistance to viral protease inhibitors: The substrate envelope.- Resistance to new Direct-Acting-Antivirals against HCV.- HBV Resistance.- Resistance to antiherpetic drugs.- Influenza Resistance.

Matthias Gotte, Department of Medical Microbiology and Immunology, University of Alberta, CanadaAlbert M. Berguis, Department of Biochemistry, McGill University, CanadaGreg Matlashewski, Department of Microbiology and Immunology, McGill University, CanadaDonald Sheppard, Department of Microbiology and Immunology, McGill University, CanadaMark A. Wainberg, Department of Microbiology and Immunology, McGill University, Canada

• Bacteria.- Origins of antibiotic resistance (Resistome).- Dissemination of antibiotic resistance.- Mechanisms of antibiotic resistance.-Strategies for combating antibiotic resistance.- Multiple-drug-resistant bacteria.- Resistant Tuberculosis.- MRSA.- Fungi.- Microevolution of drug resistance.- Environmental induction of azole resistance in medical molds.- Echinocandin resistance in medically relevant fungi.- Role of drug efflux in azole resistance.- Parasites.- Drug-resistant Leishmania.- Drug resistance in Helminth infections.- Drug resistance in Malaria.- Drug resistance in schistosome infections.- Drug resistance in trypanosome infections.- HIV.- Resistance to RT inhibitors.- Resistance to Integrase Inhibitors.- Resistance to Entry inhibitors.- Resistance Testing.- Virology.- Resistance to viral protease inhibitors: The substrate envelope.- Resistance to new Direct-Acting-Antivirals against HCV.- HBV Resistance.- Resistance to antiherpetic drugs.- Influenza Resistance.

Matthias Gotte, Department of Medical Microbiology and Immunology, University of Alberta, CanadaAlbert M. Berguis, Department of Biochemistry, McGill University, CanadaGreg Matlashewski, Department of Microbiology and Immunology, McGill University, CanadaDonald Sheppard, Department of Microbiology and Immunology, McGill University, CanadaMark A. Wainberg, Department of Microbiology and Immunology, McGill University, Canada

• Bacteria.- Origins of antibiotic resistance (Resistome).- Dissemination of antibiotic resistance.- Mechanisms of antibiotic resistance.-Strategies for combating antibiotic resistance.- Multiple-drug-resistant bacteria.- Resistant Tuberculosis.- MRSA.- Fungi.- Microevolution of drug resistance.- Environmental induction of azole resistance in medical molds.- Echinocandin resistance in medically relevant fungi.- Role of drug efflux in azole resistance.- Parasites.- Drug-resistant Leishmania.- Drug resistance in Helminth infections.- Drug resistance in Malaria.- Drug resistance in schistosome infections.- Drug resistance in trypanosome infections.- HIV.- Resistance to RT inhibitors.- Resistance to Integrase Inhibitors.- Resistance to Entry inhibitors.- Resistance Testing.- Virology.- Resistance to viral protease inhibitors: The substrate envelope.- Resistance to new Direct-Acting-Antivirals against HCV.- HBV Resistance.- Resistance to antiherpetic drugs.- Influenza Resistance.